C
China Chemical & Pharmaceutical Co Ltd
TWSE:1701
China Chemical & Pharmaceutical Co Ltd
TWSE:1701
Price:
21.15
TWD
Market Closed
Market Cap:
NT$6.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Chemical & Pharmaceutical Co Ltd
TWSE:1701
|
TW |
|
P
|
Peninsula Group Ltd
TASE:PEN
|
IL |
|
Noumi Ltd
ASX:NOU
|
AU |
|
B
|
Bank Albilad Sjsc
SAU:1140
|
SA |
|
Appotronics Corp Ltd
SSE:688007
|
CN |
|
B
|
Beijing Hanyi Innovation Technology Co Ltd
SZSE:301270
|
CN |
|
I
|
InspireMD Inc
XBER:II2
|
IL |
|
Innocean Worldwide Inc
KRX:214320
|
KR |
|
Thesis Gold Inc
XTSX:TAU
|
CA |
|
T
|
Telenet Group Holding NV
XBER:T4I
|
BE |
|
PAVmed Inc
NASDAQ:PAVM
|
US |
|
Westport Fuel Systems Inc
TSX:WPRT
|
CA |
|
KT Corp
NYSE:KT
|
KR |
Balance Sheet
Balance Sheet Decomposition
China Chemical & Pharmaceutical Co Ltd
China Chemical & Pharmaceutical Co Ltd
Balance Sheet Decomposition is not available for
China Chemical & Pharmaceutical Co Ltd
China Chemical & Pharmaceutical Co Ltd
Balance Sheet
China Chemical & Pharmaceutical Co Ltd
China Chemical & Pharmaceutical Co Ltd
Currency: TWD
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
796
|
702
|
629
|
764
|
595
|
704
|
1 034
|
849
|
438
|
445
|
|
| Cash |
785
|
684
|
623
|
755
|
586
|
704
|
1 033
|
848
|
436
|
442
|
|
| Cash Equivalents |
11
|
17
|
6
|
9
|
9
|
0
|
1
|
1
|
2
|
3
|
|
| Short-Term Investments |
18
|
52
|
28
|
31
|
29
|
72
|
0
|
97
|
414
|
45
|
|
| Total Receivables |
1 771
|
1 834
|
2 002
|
2 147
|
2 343
|
2 424
|
2 440
|
2 321
|
2 554
|
2 459
|
|
| Accounts Receivables |
1 064
|
1 132
|
1 213
|
1 359
|
1 581
|
1 698
|
1 727
|
1 565
|
1 759
|
1 581
|
|
| Other Receivables |
707
|
702
|
790
|
788
|
762
|
726
|
713
|
755
|
795
|
878
|
|
| Inventory |
1 548
|
1 485
|
1 605
|
1 699
|
2 135
|
2 181
|
2 402
|
2 266
|
2 481
|
2 585
|
|
| Other Current Assets |
0
|
54
|
61
|
83
|
75
|
117
|
51
|
34
|
52
|
51
|
|
| Total Current Assets |
4 397
|
4 126
|
4 326
|
4 723
|
5 176
|
5 498
|
5 927
|
5 567
|
5 939
|
5 583
|
|
| PP&E Net |
4 331
|
4 342
|
4 205
|
4 069
|
4 000
|
4 352
|
4 365
|
4 252
|
4 299
|
4 541
|
|
| PP&E Gross |
4 331
|
4 342
|
4 205
|
4 069
|
4 000
|
4 352
|
4 365
|
4 252
|
4 299
|
4 541
|
|
| Accumulated Depreciation |
1 409
|
1 617
|
1 840
|
2 057
|
2 261
|
2 481
|
2 686
|
2 895
|
3 158
|
3 390
|
|
| Intangible Assets |
10
|
9
|
34
|
32
|
32
|
24
|
28
|
16
|
22
|
18
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1 211
|
1 101
|
1 095
|
1 129
|
1 188
|
1 394
|
1 705
|
2 613
|
2 232
|
2 303
|
|
| Other Long-Term Assets |
361
|
334
|
297
|
323
|
371
|
310
|
331
|
339
|
330
|
420
|
|
| Total Assets |
10 310
N/A
|
9 913
-4%
|
9 957
+0%
|
10 277
+3%
|
10 766
+5%
|
11 578
+8%
|
12 357
+7%
|
12 787
+3%
|
12 823
+0%
|
12 865
+0%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
627
|
731
|
721
|
837
|
1 026
|
898
|
961
|
799
|
850
|
864
|
|
| Accrued Liabilities |
270
|
247
|
307
|
405
|
482
|
505
|
644
|
602
|
708
|
553
|
|
| Short-Term Debt |
1 493
|
1 119
|
1 177
|
1 173
|
1 131
|
1 347
|
1 353
|
1 097
|
1 308
|
1 630
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
30
|
35
|
36
|
41
|
55
|
|
| Other Current Liabilities |
271
|
175
|
224
|
222
|
229
|
251
|
320
|
274
|
392
|
291
|
|
| Total Current Liabilities |
2 660
|
2 272
|
2 429
|
2 637
|
2 868
|
3 032
|
3 313
|
2 807
|
3 300
|
3 393
|
|
| Long-Term Debt |
1 625
|
1 599
|
1 640
|
1 679
|
1 828
|
2 294
|
2 111
|
1 902
|
1 803
|
1 752
|
|
| Deferred Income Tax |
131
|
129
|
122
|
115
|
128
|
129
|
138
|
172
|
185
|
151
|
|
| Minority Interest |
26
|
48
|
46
|
41
|
31
|
33
|
35
|
34
|
37
|
38
|
|
| Other Liabilities |
410
|
423
|
268
|
242
|
241
|
184
|
169
|
118
|
105
|
99
|
|
| Total Liabilities |
4 852
N/A
|
4 472
-8%
|
4 505
+1%
|
4 713
+5%
|
5 096
+8%
|
5 671
+11%
|
5 765
+2%
|
5 033
-13%
|
5 430
+8%
|
5 432
+0%
|
|
| Equity | |||||||||||
| Common Stock |
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
2 981
|
|
| Retained Earnings |
1 559
|
1 713
|
1 803
|
1 938
|
2 101
|
2 260
|
2 767
|
3 617
|
3 873
|
3 979
|
|
| Additional Paid In Capital |
642
|
643
|
643
|
645
|
645
|
646
|
646
|
647
|
648
|
648
|
|
| Unrealized Security Profit/Loss |
240
|
81
|
54
|
85
|
38
|
146
|
311
|
631
|
5
|
31
|
|
| Treasury Stock |
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
28
|
|
| Other Equity |
63
|
52
|
1
|
57
|
65
|
98
|
86
|
94
|
86
|
117
|
|
| Total Equity |
5 458
N/A
|
5 441
0%
|
5 452
+0%
|
5 563
+2%
|
5 671
+2%
|
5 906
+4%
|
6 592
+12%
|
7 754
+18%
|
7 393
-5%
|
7 432
+1%
|
|
| Total Liabilities & Equity |
10 310
N/A
|
9 913
-4%
|
9 957
+0%
|
10 277
+3%
|
10 766
+5%
|
11 578
+8%
|
12 357
+7%
|
12 787
+3%
|
12 823
+0%
|
12 865
+0%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
297
|
297
|
297
|
297
|
297
|
297
|
297
|
297
|
297
|
297
|
|
Switch to:
Switch to:
See Also
Discover More
